2017 Bulgaria Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies

March 2017 | 400 pages | ID: 23C5D979430EN
Venture Planning Group

Abstracts

This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.

The report provides test volume and sales forecasts; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du)

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.

Competitive Assessments

• Strategic assessments of major suppliers and emerging market entrants, including their sales, M&A, product portfolios, marketing tactics, and new products in R&D.

Market Segmentation Analysis

• Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT.

Current and Emerging Products

• Analysis of current and emerging blood typing, grouping and infectious disease NAT screening assays.
• Review of automated and semi-automated molecular and immunohematology analyzers.

Technology Review

• Assessment of current and emerging technologies, and their potential applications for the blood banking market.
• Comprehensive lists of companies developing or marketing new technologies and products, by test.

Blood Group Genotyping

PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing

Microarrays

BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing

Strategic Recommendations

• New product development opportunities for blood typing, grouping and infectious disease NAT assays and instrumentation with significant market appeal.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.

Contains 400 pages and 12 tables

Contents

1. INTRODUCTION

2. TECHNOLOGY AND MARKET OVERVIEW

A. Major Blood Typing, Grouping and Infectious Disease Screening Tests
  1. BLOOD TYPING AND GROUPING TESTS
    a. ABO
    b. Antibody Panels
    c. Antibody Screening
    d. Antigen Typing
    e. Antiglobulin Test
    f. Crossmatch
    g. HLA Typing
    h. Rh
    i. Other Blood Groups
  2. BLOOD GROUP GENOTYPING
  3. INFECTIOUS DISEASE SCREENING TESTS
    a. AIDS
    b. Hepatitis
  Hepatitis A
  Hepatitis B
  Hepatitis C
  Hepatitis D (Delta Hepatitis)
  Hepatitis E
  Hepatitis G
  Hepatitis D (Delta Agent)
    c. Cytomegalovirus
    d. Syphilis
    e. West Nile Virus
    f. Parvovirus B19
    g. Creutzfeldt Jakob’s Disease
    h. Malaria
    i. Chagas Disease
    j. Babesiosis
  4. PATHOGEN REDUCTION
  5. LEUKOCYTE REDUCTION
B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers
C. Major In Vitro Diagnostic Technologies and Their Potential Applications
  1. MOLECULAR DIAGNOSTICS
  2. MONOCLONAL AND POLYCLONAL ANTIBODIES
  3. IMMUNOASSAYS
  4. MICROTITRATION PLATES
  5. IT AND AUTOMATION
  6. LASERS
  7. ROBOTICS
  8. SYNTHETIC RED CELL SUBSTITUTES
  9. GENETICALLY ENGINEERED BLOOD COMPONENTS
  10. BLOOD PRESERVATION
  11. AUTOLOGOUS BLOOD TRANSFUSION/FREEZING

3. MARKET SIZE AND GROWTH: VOLUME AND SALES FORECASTS FOR 40 BLOOD

Typing, Grouping and Infectious Disease Screening Tests

4. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Molecular Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary

5. ALTERNATIVE MARKET PENETRATION STRATEGIES

6. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

7. COMPETITIVE ASSESSMENTS

  Abbott
  Beckman Coulter/Danaher
  Becton Dickinson
  Biokit
  BioMerieux
  Bio-Rad
  CellMark Forensics/LabCorp
  Diagast
  DiaSorin
  Fujirebio
  Hologic/Genrobe
  Grifols
  Immucor
  Ortho    Clinical Diagnostics
  Proteome Sciences
  Quest Diagnostics
  Quidel
  Roche
  Siemens
  Tecan

List Of Tables

LIST OF TABLES

Executive Summary Table: Total Blood Bank Test Volume and Reagent Sales
Forecast by Test Category
All Market Segments Blood Typing And Grouping Test Volume Forecast
All Market Segments Infectious Disease Screening Test Volume Forecast
All Market Segments Blood Typing And Grouping Reagent Market Forecast by Major Test
All Market Segments Infectious Disease Screening Reagent Market Forecast by Test
Major Companies Developing or Marketing Blood Typing and Grouping Tests
Major Companies Developing or Marketing HLA Typing Tests
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Blood Bank Analyzers